The Pharma Data

NOVEMBER 30, 2020

30, 2020 – Nearly 15% of talc-based cosmetic products analyzed in a recent study contained asbestos. She noted that EWG’s online database has identified more than 2,000 personal care products that contain talc, including more than 1,000 loose or pressed powders that could pose an inhalation risk. MONDAY, Nov.

Containment 52

Containment Production Cosmetics Contamination 52

XTalks

JUNE 1, 2022

Xtalks learned more about BONESUPPORT and its first FDA-approved drug-device combination product Cerament G through an email interview with BONESUPPORT’s CEO Emil Billbäck. In May this year, BONESUPPORT received market authorization in the US for its drug-device combination product Cerament G. Read on to learn more!

Filler 98

Filler FDA Approval Production Marketing 98

XTalks

APRIL 4, 2024

Founded in 2015, MALK Organics has become synonymous with quality and innovation in alternative milk products. The company has since emerged as a leader in the alternative milk space, continually innovating and expanding its product range to meet consumer demand for healthier options. million across three rounds of funding.

Branding 104

Branding Filler Production Marketing 104

Pharmaceutical Technology

MAY 10, 2023

Microparticles can be present as a contamination of products such as pharmaceuticals and electronics, or as an air pollutant. Alternatively, they can come as a product component of formulations such as cleaning agents and polymers. Particle analysis on a micro-scale is a significant topic in several fields of application.

Contamination 130

Contamination Filler Bioavailability Production 130

XTalks

MAY 14, 2024

The company recently expanded its product line with a new single-ingredient SweetLeaf Xylitol Reduced Calorie Sweetener. “Our SweetLeaf Xylitol adds another excellent option with all of the same plant-based, nothing-artificial benefits as our other products.”

Filler 52

Filler Branding Production Containment 52

The Pharma Data

OCTOBER 22, 2021

Novartis blazoned moment that it has inked an original agreement to work its manufacturing capacity and capabilities to address the COVID-19 epidemic by expanding its support of the filler and finish of the Pfizer-BioNTech COVID-19 vaccine. This new agreement follows a first contract inked before this time.

Vaccination 52

Vaccination Vaccine Filler Manufacturing 52

Pharmacy Checkers

NOVEMBER 12, 2020

Kesselheim and Bollyky write: “FDA approvals are specific to the information in the NDA or ANDA, including: the manufacturer, product, and its use; manufacturing location, formulation, source, and specifications of active ingredients; processing methods; manufacturing controls; labeling; and appearance.”.

FDA Approval 62

FDA Approval Drugs Filler Manufacturing 62